Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma Pigmentosum.
Xeroderma Pigmentosum
adherence
illness perceptions
photoprotection
treatment beliefs
Journal
British journal of health psychology
ISSN: 2044-8287
Titre abrégé: Br J Health Psychol
Pays: England
ID NLM: 9605409
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
23
11
2018
revised:
15
04
2019
pubmed:
12
6
2019
medline:
30
11
2019
entrez:
12
6
2019
Statut:
ppublish
Résumé
Xeroderma pigmentosum (XP) is an extremely rare genetic disorder (approximately 100 known cases in the United Kingdom), where DNA damage caused by ultraviolet radiation in daylight cannot be repaired. Adherence to photoprotection is essential to prevent skin cancer. We investigated psychological correlates of photoprotection in the XP population of Western Europe and the United States. Cross-sectional survey of adults with XP and caregivers of patients <16 years and those with cognitive impairment in the United Kingdom, Germany, the United States, and France (n = 156). Photoprotection activities to protect the face and body when outdoors; avoidance of going outside during daylight hours; intention; self-efficacy; and social support were assessed using measures developed for this study. Participants answered questions about their illness representations of XP (BIPQ); beliefs about photoprotection (BMQ); automaticity (i.e., without conscious effort) (SRBAI); clinical and demographic characteristics. Ordinal logistic regressions determined factors associated with photoprotection. One third did not achieve optimal face photoprotection. After controlling for demographic and clinical factors, modifiable correlates of higher photoprotection included greater perceived control of XP, stronger beliefs in necessity and effectiveness of photoprotection, and higher intention. Avoidance of going outside was associated with greater photoprotection concerns, more serious illness consequences, and higher XP-related distress. Greater automaticity and higher self-efficacy were associated with better protection across all outcomes. Approximately half of all known cases across three European countries participated. Identified modifiable predictors of photoprotection may be targeted by interventions to reduce the incidence of skin cancers in the immediate future, when a treatment breakthrough is unlikely. Statement of contribution What is already known on this subject? Adherence to photoprotection in other populations at elevated risk from skin cancer is poor; however, the level in XP is unknown. Research across chronic conditions shows that adherence to treatment and lifestyle recommendations are influenced by illness perceptions, self-efficacy, and treatment beliefs. Studies on photoprotection conducted with the general population have found that perceived risk, perceptions of ultraviolet radiation (UVR) protection, self-efficacy for the behaviour, and automaticity (behaviours that are enacted with little conscious awareness) are related to better photoprotection. What does this study add? This is the first international survey to examine adherence and its correlates in people with XP (an under-researched group at very high risk of fatal skin cancer). Adherence varies and at least one third have potential for improvement. Perceptions about XP, photoprotection beliefs, self-efficacy, intention, and automaticity were associated with photoprotection of the face and body when outdoors. Negative emotional representations of XP were associated with avoidance of going outside during daylight hours.
Identifiants
pubmed: 31183946
doi: 10.1111/bjhp.12375
pmc: PMC6772157
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
668-686Subventions
Organisme : Department of Health
ID : RP-PG-1212-20009
Pays : United Kingdom
Informations de copyright
© 2019 The Authors. British Journal of Health Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.
Références
Br J Health Psychol. 2018 Nov;23(4):949-966
pubmed: 30014548
Psychol Bull. 2015 Nov;141(6):1178-204
pubmed: 26501228
J Psychosom Res. 2009 Jul;67(1):17-23
pubmed: 19539814
J Behav Med. 2016 Dec;39(6):1076-1091
pubmed: 26980098
Psychol Health. 2011 Jul;26(7):799-818
pubmed: 21432728
Orphanet J Rare Dis. 2011 Nov 01;6:70
pubmed: 22044607
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
Diabetes Care. 2011 Feb;34(2):338-40
pubmed: 21270191
Health Psychol Rev. 2015;9(3):277-95
pubmed: 25207647
J Med Genet. 2011 Mar;48(3):168-76
pubmed: 21097776
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Prev Med. 2016 Jul;88:153-67
pubmed: 27090434
Health Psychol. 2018 Dec;37(12):1145-1158
pubmed: 30221970
Environ Res. 2016 Apr;146:200-6
pubmed: 26775001
Health Psychol. 2004 Mar;23(2):207-18
pubmed: 15008666
DNA Repair (Amst). 2008 May 3;7(5):744-50
pubmed: 18329345
BMC Public Health. 2016 Jul 13;16:565
pubmed: 27411518
J Health Psychol. 2019 Dec;24(14):2031-2041
pubmed: 28810476
Eur Psychol. 2019;24(1):7-25
pubmed: 31496632
Ann Behav Med. 2013 Dec;46(3):358-68
pubmed: 23670112
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2199-210
pubmed: 20643826
PLoS One. 2013 Dec 02;8(12):e80633
pubmed: 24312488
Psychol Health. 2016 Nov;31(11):1272-92
pubmed: 27334551
J Clin Pharmacol. 2016 Mar;56(3):257-9
pubmed: 26211513
BMJ Open. 2017 Aug 21;7(8):e018364
pubmed: 28827277
Patient Educ Couns. 2016 May;99(5):706-17
pubmed: 26613666
BMJ Open. 2013 Aug 07;3(8):
pubmed: 23929922
J Behav Med. 2016 Dec;39(6):935-946
pubmed: 27515801
Br J Dermatol. 2013 Dec;169(6):1279-87
pubmed: 23889214
Front Pharmacol. 2013 Jul 25;4:91
pubmed: 23898295
BMJ Open. 2019 Feb 19;9(2):e024445
pubmed: 30782905
Psychol Health. 2013;28(5):477-94
pubmed: 23252669
Br J Health Psychol. 2018 May;23(2):229-237
pubmed: 29265545
Am J Manag Care. 2012 Dec 01;18(12):e461-7
pubmed: 23286676
J Cancer Res Clin Oncol. 2016 Jun;142(6):1273-83
pubmed: 26642962
Photodermatol Photoimmunol Photomed. 2020 Mar;36(2):118-125
pubmed: 31596975
Int J Behav Nutr Phys Act. 2012 Aug 30;9:102
pubmed: 22935297
Photodermatol Photoimmunol Photomed. 2014 Apr-Jun;30(2-3):146-52
pubmed: 24417420
Int J Behav Med. 2012 Mar;19(1):65-72
pubmed: 21394444
Psychol Bull. 2017 Nov;143(11):1117-1154
pubmed: 28805401
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Photochem Photobiol Sci. 2019 Feb 13;18(2):467-476
pubmed: 30511738
Science. 2012 Sep 21;337(6101):1492-5
pubmed: 22997327
Psychol Health. 2008;23(1):91-112
pubmed: 25159909